AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MYRIAD GENETICS INC Director's Dealing 2023

Nov 1, 2023

32566_dirs_2023-11-01_7443dc21-fef0-4aa0-873c-a24befc73224.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2023-10-31

Reporting Person: Lambert Nicole (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	223993	Direct